Records containing: Kidney Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-07Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2013-05-30Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2013-05-24An Open-label, Single-Arm Study to Assess the Safety of Darbepoetin Alfa Manufactured by a Serum Free Bioreactor Technology in Subjects With Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2013-05-08A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
-
CLINICAL_TRIALS study record update · 2012-12-06A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-08-27A Randomized, Single-Blind, Placebo-Controlled, Adaptive, Ascending Dose Study to Evaluate the Effects of TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Mild to Moderate Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2012-07-16A 30-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy in Dyslipidemic Subjects With Stage 3 Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2012-07-09The Use of Campath-1H, Tacrolimus, and Sirolimus Followed by Sirolimus Withdrawal in Renal Transplant Patients
-
CLINICAL_TRIALS study record update · 2012-06-21Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance (ITN022ST)
-
CLINICAL_TRIALS study record update · 2012-03-14Evaluation of Performance and Safety Profile of Xevonta High Flux Dialyzer With Special Focus on Determination of in Vivo Ultrafiltration Coefficient in Patients With CKD
-
CLINICAL_TRIALS study record update · 2012-02-07Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2011-01-21Aranesp® Monthly Preference Study
-
CLINICAL_TRIALS study record update · 2011-01-19A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
-
CLINICAL_TRIALS study record update · 2010-10-27A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease (CKD) Receiving Hemodialysis
-
CLINICAL_TRIALS study record update · 2010-10-05Tolerance Induction Following Human Renal Transplantation Using Treatment With a Humanized Monoclonal Antibody Against CD52 (Campath-1H)
-
CLINICAL_TRIALS study record update · 2010-09-02Trial to Reduce Cardiovascular Events With Aranesp® Therapy
-
CLINICAL_TRIALS study record update · 2010-05-28Prediction Equations for Glomerular Filtration Rate in Children Based on Serum Cystatin C and Body Cell Mass
-
CLINICAL_TRIALS study record update · 2010-03-10A Randomized, Open-label Study to Compare the Safety and Efficacy of Cyclosporin Dose Reduction With Cyclosporin Elimination in de Novo Renal Allograft Recipients Receiving Rapamune
-
CLINICAL_TRIALS study record update · 2010-03-05A Multicenter Study Using Once Every Other Week Subcutaneous Administration of Aranesp™ (Darbepoetin Alfa) and Iron Guided Algorithms to Treat Subjects With Anemia of Chronic Renal Insufficiency (CRI)
-
CLINICAL_TRIALS study record update · 2010-03-02Improving Outcomes in Diabetic Nephropathy
-
CLINICAL_TRIALS study record update · 2010-02-19Disease/Case Management of Patients Receiving ARANESP™ (Darbepoetin Alfa) to Treat the Anemia of Chronic Renal Insufficiency (CRI)
-
CLINICAL_TRIALS study record update · 2010-02-12Prediction of Impaired Myocardial Fatty Acid Metabolism and Insulin Resistance for Cardiac Death of Hemodialysis Patients With Normal Coronary Arteries
-
CLINICAL_TRIALS study record update · 2010-01-20Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)
-
CLINICAL_TRIALS study record update · 2009-10-16A Multicenter Study Evaluating Once Every Other Week Subcutaneous Administration of Aranesp (Darbepoetin Alfa) in Subjects With Anemia of Chronic Renal Insufficiency (CRI)
-
CLINICAL_TRIALS study record update · 2009-07-10A Multi-Center, Single-Arm Study Evaluating De Novo Once Every Two Week Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis